Medical Care
Global Cancer Tissue Diagnostics Market Research Report 2025
- Sep 18, 25
- ID: 507026
- Pages: 74
- Figures: 72
- Views: 15
This report aims to provide a comprehensive presentation of the global market for Cancer Tissue Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Tissue Diagnostics.
The Cancer Tissue Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Tissue Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Tissue Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam plc.
Segment by Type
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Tissue Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Cancer Tissue Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Tissue Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Tissue Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Thermo Fisher Scientific Inc.
Bio Rad Laboratories Inc.
Abbott
Enzo Life Sciences, Inc.
Agilent Technologies, Inc.
Cancer Genetics Inc.
Merck KGaA (Sigma-Aldrich Co. LLC)
Abcam plc.
Segment by Type
Immunohistochemistry (IHC) Test
In Situ Hybridisation Test
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Tissue Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunohistochemistry (IHC) Test
1.2.3 In Situ Hybridisation Test
1.3 Market by Application
1.3.1 Global Cancer Tissue Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tissue Diagnostics Market Perspective (2020-2031)
2.2 Global Cancer Tissue Diagnostics Growth Trends by Region
2.2.1 Global Cancer Tissue Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Tissue Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Cancer Tissue Diagnostics Market Dynamics
2.3.1 Cancer Tissue Diagnostics Industry Trends
2.3.2 Cancer Tissue Diagnostics Market Drivers
2.3.3 Cancer Tissue Diagnostics Market Challenges
2.3.4 Cancer Tissue Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Revenue
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Tissue Diagnostics Revenue
3.4 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2024
3.5 Global Key Players of Cancer Tissue Diagnostics Head office and Area Served
3.6 Global Key Players of Cancer Tissue Diagnostics, Product and Application
3.7 Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tissue Diagnostics Breakdown Data by Type
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031)
5 Cancer Tissue Diagnostics Breakdown Data by Application
5.1 Global Cancer Tissue Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2020-2031)
6.2 North America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
6.4 North America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2020-2031)
7.2 Europe Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025)
7.4 Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tissue Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Cancer Tissue Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Tissue Diagnostics Market Size (2020-2031)
9.2 Latin America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tissue Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
11.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Details
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Bio Rad Laboratories Inc.
11.4.1 Bio Rad Laboratories Inc. Company Details
11.4.2 Bio Rad Laboratories Inc. Business Overview
11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
11.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.4.5 Bio Rad Laboratories Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Cancer Tissue Diagnostics Introduction
11.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Details
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 Agilent Technologies, Inc.
11.7.1 Agilent Technologies, Inc. Company Details
11.7.2 Agilent Technologies, Inc. Business Overview
11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
11.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.7.5 Agilent Technologies, Inc. Recent Development
11.8 Cancer Genetics Inc.
11.8.1 Cancer Genetics Inc. Company Details
11.8.2 Cancer Genetics Inc. Business Overview
11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
11.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.8.5 Cancer Genetics Inc. Recent Development
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
11.10 Abcam plc.
11.10.1 Abcam plc. Company Details
11.10.2 Abcam plc. Business Overview
11.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
11.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.10.5 Abcam plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunohistochemistry (IHC) Test
1.2.3 In Situ Hybridisation Test
1.3 Market by Application
1.3.1 Global Cancer Tissue Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tissue Diagnostics Market Perspective (2020-2031)
2.2 Global Cancer Tissue Diagnostics Growth Trends by Region
2.2.1 Global Cancer Tissue Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Tissue Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Cancer Tissue Diagnostics Market Dynamics
2.3.1 Cancer Tissue Diagnostics Industry Trends
2.3.2 Cancer Tissue Diagnostics Market Drivers
2.3.3 Cancer Tissue Diagnostics Market Challenges
2.3.4 Cancer Tissue Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Revenue
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Tissue Diagnostics Revenue
3.4 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2024
3.5 Global Key Players of Cancer Tissue Diagnostics Head office and Area Served
3.6 Global Key Players of Cancer Tissue Diagnostics, Product and Application
3.7 Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tissue Diagnostics Breakdown Data by Type
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031)
5 Cancer Tissue Diagnostics Breakdown Data by Application
5.1 Global Cancer Tissue Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2020-2031)
6.2 North America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
6.4 North America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2020-2031)
7.2 Europe Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025)
7.4 Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tissue Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Cancer Tissue Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Tissue Diagnostics Market Size (2020-2031)
9.2 Latin America Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tissue Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Cancer Tissue Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Details
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Details
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
11.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Details
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Bio Rad Laboratories Inc.
11.4.1 Bio Rad Laboratories Inc. Company Details
11.4.2 Bio Rad Laboratories Inc. Business Overview
11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
11.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.4.5 Bio Rad Laboratories Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Cancer Tissue Diagnostics Introduction
11.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.5.5 Abbott Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Details
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 Agilent Technologies, Inc.
11.7.1 Agilent Technologies, Inc. Company Details
11.7.2 Agilent Technologies, Inc. Business Overview
11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
11.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.7.5 Agilent Technologies, Inc. Recent Development
11.8 Cancer Genetics Inc.
11.8.1 Cancer Genetics Inc. Company Details
11.8.2 Cancer Genetics Inc. Business Overview
11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
11.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.8.5 Cancer Genetics Inc. Recent Development
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
11.10 Abcam plc.
11.10.1 Abcam plc. Company Details
11.10.2 Abcam plc. Business Overview
11.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
11.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025)
11.10.5 Abcam plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunohistochemistry (IHC) Test
Table 3. Key Players of In Situ Hybridisation Test
Table 4. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Tissue Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Tissue Diagnostics Market Share by Region (2020-2025)
Table 8. Global Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Tissue Diagnostics Market Share by Region (2026-2031)
Table 10. Cancer Tissue Diagnostics Market Trends
Table 11. Cancer Tissue Diagnostics Market Drivers
Table 12. Cancer Tissue Diagnostics Market Challenges
Table 13. Cancer Tissue Diagnostics Market Restraints
Table 14. Global Cancer Tissue Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Tissue Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
Table 17. Ranking of Global Top Cancer Tissue Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Tissue Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Tissue Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Cancer Tissue Diagnostics, Product and Application
Table 21. Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Tissue Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Tissue Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Tissue Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd. Company Details
Table 47. F. Hoffmann-La Roche Ltd. Business Overview
Table 48. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product
Table 49. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd. Recent Development
Table 51. Danaher Corporation Company Details
Table 52. Danaher Corporation Business Overview
Table 53. Danaher Corporation Cancer Tissue Diagnostics Product
Table 54. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Danaher Corporation Recent Development
Table 56. Thermo Fisher Scientific Inc. Company Details
Table 57. Thermo Fisher Scientific Inc. Business Overview
Table 58. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product
Table 59. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Scientific Inc. Recent Development
Table 61. Bio Rad Laboratories Inc. Company Details
Table 62. Bio Rad Laboratories Inc. Business Overview
Table 63. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product
Table 64. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Bio Rad Laboratories Inc. Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Cancer Tissue Diagnostics Product
Table 69. Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Enzo Life Sciences, Inc. Company Details
Table 72. Enzo Life Sciences, Inc. Business Overview
Table 73. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product
Table 74. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Enzo Life Sciences, Inc. Recent Development
Table 76. Agilent Technologies, Inc. Company Details
Table 77. Agilent Technologies, Inc. Business Overview
Table 78. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product
Table 79. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Agilent Technologies, Inc. Recent Development
Table 81. Cancer Genetics Inc. Company Details
Table 82. Cancer Genetics Inc. Business Overview
Table 83. Cancer Genetics Inc. Cancer Tissue Diagnostics Product
Table 84. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Cancer Genetics Inc. Recent Development
Table 86. Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
Table 87. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
Table 88. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product
Table 89. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
Table 91. Abcam plc. Company Details
Table 92. Abcam plc. Business Overview
Table 93. Abcam plc. Cancer Tissue Diagnostics Product
Table 94. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Abcam plc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Cancer Tissue Diagnostics Picture
Figure 2. Global Cancer Tissue Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Tissue Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Immunohistochemistry (IHC) Test Features
Figure 5. In Situ Hybridisation Test Features
Figure 6. Global Cancer Tissue Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Tissue Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Cancer Tissue Diagnostics Report Years Considered
Figure 12. Global Cancer Tissue Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cancer Tissue Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Tissue Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Cancer Tissue Diagnostics Market Share by Players in 2024
Figure 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2024
Figure 18. North America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Tissue Diagnostics Market Share by Region (2020-2031)
Figure 32. China Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 48. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 49. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 50. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 51. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 52. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 54. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 55. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 56. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunohistochemistry (IHC) Test
Table 3. Key Players of In Situ Hybridisation Test
Table 4. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Tissue Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Tissue Diagnostics Market Share by Region (2020-2025)
Table 8. Global Cancer Tissue Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Tissue Diagnostics Market Share by Region (2026-2031)
Table 10. Cancer Tissue Diagnostics Market Trends
Table 11. Cancer Tissue Diagnostics Market Drivers
Table 12. Cancer Tissue Diagnostics Market Challenges
Table 13. Cancer Tissue Diagnostics Market Restraints
Table 14. Global Cancer Tissue Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Tissue Diagnostics Market Share by Players (2020-2025)
Table 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
Table 17. Ranking of Global Top Cancer Tissue Diagnostics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Tissue Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Tissue Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of Cancer Tissue Diagnostics, Product and Application
Table 21. Global Key Players of Cancer Tissue Diagnostics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Tissue Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Tissue Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Tissue Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Tissue Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 46. F. Hoffmann-La Roche Ltd. Company Details
Table 47. F. Hoffmann-La Roche Ltd. Business Overview
Table 48. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product
Table 49. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 50. F. Hoffmann-La Roche Ltd. Recent Development
Table 51. Danaher Corporation Company Details
Table 52. Danaher Corporation Business Overview
Table 53. Danaher Corporation Cancer Tissue Diagnostics Product
Table 54. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 55. Danaher Corporation Recent Development
Table 56. Thermo Fisher Scientific Inc. Company Details
Table 57. Thermo Fisher Scientific Inc. Business Overview
Table 58. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product
Table 59. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 60. Thermo Fisher Scientific Inc. Recent Development
Table 61. Bio Rad Laboratories Inc. Company Details
Table 62. Bio Rad Laboratories Inc. Business Overview
Table 63. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product
Table 64. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 65. Bio Rad Laboratories Inc. Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Cancer Tissue Diagnostics Product
Table 69. Abbott Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Enzo Life Sciences, Inc. Company Details
Table 72. Enzo Life Sciences, Inc. Business Overview
Table 73. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product
Table 74. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 75. Enzo Life Sciences, Inc. Recent Development
Table 76. Agilent Technologies, Inc. Company Details
Table 77. Agilent Technologies, Inc. Business Overview
Table 78. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product
Table 79. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 80. Agilent Technologies, Inc. Recent Development
Table 81. Cancer Genetics Inc. Company Details
Table 82. Cancer Genetics Inc. Business Overview
Table 83. Cancer Genetics Inc. Cancer Tissue Diagnostics Product
Table 84. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 85. Cancer Genetics Inc. Recent Development
Table 86. Merck KGaA (Sigma-Aldrich Co. LLC) Company Details
Table 87. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
Table 88. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product
Table 89. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 90. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
Table 91. Abcam plc. Company Details
Table 92. Abcam plc. Business Overview
Table 93. Abcam plc. Cancer Tissue Diagnostics Product
Table 94. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2020-2025) & (US$ Million)
Table 95. Abcam plc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Cancer Tissue Diagnostics Picture
Figure 2. Global Cancer Tissue Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Tissue Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. Immunohistochemistry (IHC) Test Features
Figure 5. In Situ Hybridisation Test Features
Figure 6. Global Cancer Tissue Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Tissue Diagnostics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Cancer Tissue Diagnostics Report Years Considered
Figure 12. Global Cancer Tissue Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cancer Tissue Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Tissue Diagnostics Market Share by Region: 2024 VS 2031
Figure 15. Global Cancer Tissue Diagnostics Market Share by Players in 2024
Figure 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2024
Figure 18. North America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 20. United States Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 24. Germany Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Tissue Diagnostics Market Share by Region (2020-2031)
Figure 32. China Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 40. Mexico Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Tissue Diagnostics Market Share by Country (2020-2031)
Figure 44. Turkey Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cancer Tissue Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 48. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 49. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 50. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 51. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 52. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 53. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 54. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 55. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 56. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232